A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: ragged (23), shabby (1)

Oesophageal manometry test and 24-hour pH and impedance measurement test - Patients on proton pump inhibitors (PPIs) - patient information

Description
This factsheet explains what an oesophageal manometry test and a 24-hour pH and impedance measurement test are and what they
Url
/Media/UHS-website-2019/Patientinformation/Tests/Oesophageal-manometry-test-and-24-hour-pH-and-impedance-measurement-test-Patients-on-proton-pump-inhibitors-PPIs-3728-PIL.pdf

Docetaxel-Pertuzumab-Trastuzumab Ver 1.3

Description
Chemotherapy Protocol BREAST CANCER DOCETAXEL-PERTUZUMAB-TRASTUZUMAB This protocol may require funding Regimen • Breast Cancer – Docetaxel-Pertuzumab-Trastuzumab Indication • Locally advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-Pertuzumab-Trastuzumab.pdf

Carboplatin-Docetaxel-Trastuzumab

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL-TRASTUZUMAB (TCH) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Trastuzumab (TCH) Indication • Adjuvant treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Trastuzumab.pdf

Carboplatin(AUC6)Docetaxel

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel Indication • Neo-adjuvant or adjuvant treatment of triple
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CarboplatinAUC6Docetaxel.pdf

E(100)CT

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN (100) Regimen (E100CT) • Breast Cancer – Cyclophosphamide-Docetaxel-Epirubicin (100) (E100CT) Indication • Neo-adjuvant / adjuvant
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/E100CT.pdf

Cyclophosphamide-Docetaxel-Epirubicin (100)-Fluorouracil (FE100CT)

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN (100)- FLUOROURACIL Regimen (FE100CT) • Breast Cancer – Cyclophosphamide-Docetaxel-Epirubicin (100)-Fluorouracil (FE100CT) Indication • Neo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Docetaxel-Epirubicin-100-Fluorouracil.pdf

Papers Trust Board - 13 January 2026

Description
Date Time Location Chair Apologies Agenda Trust Board – Open Session 13/01/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-13-January-2026.pdf

Papers Trust Board - 11 November 2025

Description
Date Time Location Chair Agenda Trust Board – Open Session 11/11/2025 9:00 - 13:00 Conference Room, Heartbeat Education Centre
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-11-November-2025.pdf

Carboplatin-Docetaxel-Pertuzumab-Trastuzumab_IV-SC

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL- PERTUZUMABTRASTUZUMAB (IV/SC) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Pertuzumab-Trastuzumab (IV/SC) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Pertuzumab-Trastuzumab-IV-SC.pdf

EC-DPH IV (Cyclophosphamide-Epirubicin-Docetaxel-Pertuzumab-Trastuzumab IV)

Description
Please refer to the most up to date Bluteq eligibility criteria for pertuzumab and trastuzumab before prescribing.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/EC-DPH-IV-Cyclophosphamide-Epirubicin-Docetaxel-Pertuzumab-Trastuzumab-IV.pdf
61 to 70 of 81
Previous … 5 6 7 8 9 Next